This Government Contract opportunity from Department Of Health And Human Services was posted on May 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Intent to Sole Source - ORTHO Vision Equipment
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health Clinical Center intends to enter into a sole source negotiation with Quidel-Ortho Sales Company, LLC for the acquisition of the ORTHO Vision Equipment, which utilizes Quidel-Ortho Clinical Diagnostics technology. This instrument supports pretransfusion testing by determining red blood cell compatibility, thereby enhancing transfusion safety through reduced wait times and minimized human error via its automated workflow capabilities. The requirement is justified under the statutory authority that permits non-competitive procurement when only one responsible source can fulfill the agency's needs. This notice, classified as a special notice rather than a request for proposal, invites all capable vendors to submit capability statements by the specified deadline, although the government retains discretion on whether to compete the requirement. The solicitation was posted on May 27, 2026, with responses due by May 29, 2026, and pertains to the NAICS code 334516. The procurement will be conducted by the NIH in Bethesda, Maryland, with no set-aside designation applied.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: QuidelOrtho Sales Company, LLC.
Acquistion Description:
DTM uses Quidel-Ortho Clinical Diagnostics, Inc. technology to perform pretransfusion testing for blood grouping and antibody detection. It is a critical instrument in determining red blood cell compatibility for transfusion and offers the option of a fully automated workflow. The system minimizes wait time and reduces human error in support of improved transfusion safety.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-006399) by 12:00 PM eastern standard time on 05/29/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.